
- Telehealth Visits
- Insurance plan information
- Provider Type: Physician

Alfred Chung, MD
Hematology and Medical Oncology • Hematology and Medical Oncology (Leukemia)- Telehealth Visits
- Insurance plan information
- Provider Type: Physician



Alfred Chung, MD
Hematology and Medical Oncology • Hematology and Medical Oncology (Leukemia)On this page
About me
Dr. Alfred Chung is a hematologist-oncologist who cares for patients with blood cancers, including leukemias, lymphomas and myelomas. He sees patients who are in the hospital for treatment, including those who need a bone marrow transplant and those receiving chemotherapy or cellular therapies to bolster the immune system.
Chung's research centers on the study and development of new therapies for plasma cell disorders, including multiple myeloma and amyloidosis (buildup of an abnormal protein called amyloid in the organs). One specific area of study is light chain amyloidosis, in which the dysfunction of certain antibody-producing cells results in abnormal protein fibers in the organs. Chung is looking specifically at targeted therapies to treat this type of amyloidosis as well as novel therapeutic strategies in the treatment of multiple myeloma.
After earning a bachelor's degree in chemical engineering at the University of Michigan, Chung earned a medical degree at Northwestern University Feinberg School of Medicine. At Stanford Medicine, he completed a residency in internal medicine, followed by a fellowship in hematology and oncology.
Chung is a member of the American Society of Clinical Oncology, American Society of Hematology and Association of Northern California Oncologists.
Education & training
Board certification
- Medical Oncology, American Board of Internal Medicine
- Hematology, American Board of Internal Medicine/Hematology
- Internal Medicine, American Board of Internal Medicine
Fellowship
- Hematology - Oncology, Stanford University Hematopathology Fellowship
Residency
- Internal Medicine, Stanford Hospital and Clinics
Degree
- MD, Northwestern University Feinberg School of Medicine
Academic title
- Health Sciences Clinical Professor
My expertise
Specialties
- Hematology and Medical Oncology
- Hematology and Medical Oncology (Leukemia)
- Hematology and Medical Oncology (Lymphoma)
- Hematology and Medical Oncology (Multiple Myeloma)
Conditions
- Multiple Myeloma
- Light Chain (AL) Amyloidosis
- Leukemia
- Amyloidosis
Locations
My research
Clinical trials
A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple MyelomaOpens in a new window
Recruiting
Incidence of dose-limiting toxicity (DLTs), treatment-emergent adverse events (TEAEs), treatment-related AEs, and clinically significant changes in laboratory...Screening for AL Amyloidosis in Smoldering Multiple MyelomaOpens in a new window
Recruiting
With a 15-center network covering 12 states and almost 45% of the US population, we will evaluate 400 SMM patients > 40 years old who pass FLC criteria using s...A Study to Evaluate Preventive Treatments for GPRC5D-related Oral EventsOpens in a new window
Recruiting
Dysgeusia is defined as total WETT score of 25th percentile or below according to the Normative WETT-SA53 percentile table. Taste assessment will be performed...
Publications
Showing 1-6 of 82 reviews
- September 16, 20265 out of 5 Stars
Excellent experience.
- September 4, 20265 out of 5 Stars
Dr.Chung is very informative and explains things in an easy to understand way.
- August 13, 20265 out of 5 Stars
Very caring team!
- August 12, 20265 out of 5 Stars
Excellent care
- August 8, 20264.7 out of 5 Stars
Dr Chung was extremely thorough, detailed and compassionate in his explanations of my condition and recommended treatments however I have not seen any notes or visit summary on "My Chart " so I am confused as to timing and my next steps.
- August 7, 20264.9 out of 5 Stars
It would be helpful if follow-up directions for me to do were listed in the summary.
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.
The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.